Skip to main content

Joltid

Popular

Bold Therapeutics to Participate in 2026 Metals in Medicine Gordon Research Conference

VANCOUVER, BC, June 22, 2026 /PRNewswire/ — Bold Therapeutics, a clinical-stage biopharmaceutical company founded to develop and commercialize novel metallotherapeutics is headed to the prestigious 2026 Metals in Medicine Gordon Research Conference this week in Andover, New Hampshire. There,…

Read the full release →

News provided by PR Newswire.